Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features

Schizophr Res. 2009 Apr;109(1-3):94-7. doi: 10.1016/j.schres.2009.02.009. Epub 2009 Mar 5.

Abstract

We tested four genes [phenylalanine hydroxylase (PAH), the serotonin transporter (SLC6A4), monoamine oxidase B (MAOB), and the gamma-aminobutyric acid A receptor beta-3 subunit (GABRB3)] for their impact on five schizophrenia symptom factors: delusions, hallucinations, mania, depression, and negative symptoms. In a 90 family subset of the Irish Study of High Density Schizophrenia Families, the PAH 232 bp microsatellite allele demonstrated significant association with the delusions factor using both QTDT (F=8.0, p=.031) and QPDTPHASE (chi-square=12.54, p=.028). Also, a significant association between the GABRB3 191 bp allele and the hallucinations factor was detected using QPDTPHASE (chi-square=15.51, p=.030), but not QTDT (chi-square=2.07, p=.560).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Delusions / genetics
  • Family
  • Gene Frequency
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / genetics
  • Genetic Variation
  • Genome-Wide Association Study
  • Genotype
  • Hallucinations / genetics
  • Humans
  • Membrane Transport Proteins / genetics
  • Monoamine Oxidase / genetics*
  • Phenylalanine Hydroxylase / genetics*
  • Polymorphism, Genetic*
  • Polymorphism, Single Nucleotide
  • Psychotic Disorders / diagnosis
  • Psychotic Disorders / genetics*
  • Psychotic Disorders / psychology
  • Receptors, GABA / genetics
  • Schizophrenia / diagnosis
  • Schizophrenia / genetics
  • Serotonin Plasma Membrane Transport Proteins / genetics*

Substances

  • Genetic Markers
  • Membrane Transport Proteins
  • Receptors, GABA
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • Phenylalanine Hydroxylase
  • Monoamine Oxidase